HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Infectious disease relations to cesarean section.

Abstract
Patients delivered by cesarean section are at risk for postoperative infectious morbidity, especially those patients who have labored with ruptured membranes for a long period of time. The bacteria involved in these infections are predominantly those of the patient's lower genital tract, both aerobes and anaerobes. Antibiotic prophylaxis has reduced the risk of postpartum infection but has also resulted in selection of resistant bacteria. Treatment of postpartum endometritis has classically been with clindamycin plus an aminoglycoside. However, the newer beta-lactam antibiotics have proved to be just as efficacious. A significant advance in the treatment of postpartum endometritis is the use of beta-lactamase inhibitors combined with beta-lactams, such as clavulanic acid plus ticarcillin or ampicillin plus sulbactam. Regardless of which antibiotic is chosen for treatment, it is important to know the weakness of each antibiotic. For example, cephalosporins such as cefoxitin or cefotetan do not have activity against Strep. faecalis, Ent. cloacae, or Pseudomonas aerugenosa; mezlocillin, ticarcillin, or piperacillin tend to be weakest against the gram-negative facultative anaerobes; and combinations such as clindamycin plus gentamicin do not provide coverage against Strep. faecalis. This knowledge of the weakness of the different antibiotics permits appropriate additions to the antibiotic regimen and avoids irrational changes in antibiotic therapy.
AuthorsS Faro
JournalObstetrics and gynecology clinics of North America (Obstet Gynecol Clin North Am) Vol. 15 Issue 4 Pg. 685-95 (Dec 1988) ISSN: 0889-8545 [Print] United States
PMID3226672 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
Topics
  • Anti-Bacterial Agents (therapeutic use)
  • Bacterial Infections (drug therapy, etiology)
  • Cesarean Section (adverse effects)
  • Endometritis (drug therapy, etiology, microbiology)
  • Female
  • Humans
  • Pregnancy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: